NCT03834948 2023-08-22
AO-176 in Multiple Solid Tumor Malignancies
Arch Oncology
Phase 1/2 Completed
Clinical Trials
5 trialsNCT04035473 2022-04-13
A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel
Athenex, Inc.
Phase 1 Completed
NCT02730481 2021-09-13
A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies
Athenex, Inc.
Phase 1 Completed
NCT04180384 2021-07-29
A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients
Athenex, Inc.
Phase 2 Completed
NCT04046016 2019-08-06
A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
Seoul National University Hospital
Phase EARLY_PHASE1 Completed